BIGG

Multiple sclerosis in adults: management

England. National Institute for Health and Care Excellence.

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews. NICE has also produced technology ...

Multiple Sclerosis/therapy, Multiple Sclerosis/diagnosis, Ataxia/therapy, Selective Serotonin Reuptake Inhibitors/therapeutic use, Fatigue/therapy, Multiple Sclerosis/rehabilitation, Fatigue/drug therapy, Mobility Limitation, Muscle Spasticity/drug therapy, Dystonia/drug therapy, Tremor/drug therapy

Fulltext (primary link) Fulltext (alternative link)

Cannabis-based medicinal products

England. National Institute for Health and Care Excellence.

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy....

Medical Marijuana/therapeutic use, Nausea/drug therapy, Vomiting/drug therapy, Chronic Pain/drug therapy, Muscle Spasticity/drug therapy, Drug Resistant Epilepsy/drug therapy, Drug Prescriptions

Fulltext

Spasticity in under 19s: management

England. National Institute for Health and Care Excellence.

This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to se...

Muscle Spasticity/therapy, Muscle Spasticity/diagnosis, Muscle Spasticity/drug therapy, Pain Management, Diazepam/therapeutic use, Baclofen/therapeutic use, Trihexyphenidyl/therapeutic use, Levodopa/therapeutic use, Botulinum Toxins, Type A/therapeutic use, Rhizotomy

Fulltext